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Introduction
Choroidal neovascularization (CNV) is the aberrant growth of new blood vessels originating from the choroid into the subretinal space through a break in Bruch's membrane. 1 These new vessels can lead to vascular leakage, hemorrhage, formation of fibrovascular membranes, retinal detachment and eventually, if not treated, to a fibrous scar.
CNV is a major cause of visual loss and is implicated in several neovascular eye diseases such as the wet (or exudative) form of age-related macular degeneration (AMD). 2 Wet AMD is responsible for about 90% of AMD-related blindness in individuals over the age of 55, with about 200,000 new cases diagnosed every year in the United States alone. 3, 4 Laser-induced CNV (L-CNV) is a frequently used experimental technique in mice and rats that induces breaks in Bruch's membrane and stimulates blood vessel growth from the choriocapillaris. 5 The resultant CNV resembles aspects of exudative AMD and can easily be performed in rodents, producing robust subretinal vascular lesions within 14 days. L-CNV has become the "gold standard" in preclinical studies, 6 despite limitations of using rodents. 5 This model has been invaluable for the evaluation of the effects of drug therapies on CNV lesion progression 7, 8 Vascular endothelial growth factor (VEGF) has been recognized as a key proangiogenic factor in CNV. Targeting the VEGF pathway, using specific antibodies, antibody fragments, or aptamers, is a standard pharmacotherapeutic approach for wet AMD 9 and has been previously tested in L-CNV experimental models. 10, 11 Several methods for 2-dimensional (2D) evaluation of L-CNV lesions have been used including histological analysis and fluorescein angiography. 12 Measuring L-CNV lesion volume using stained choroidal flatmounts ex vivo allows 3-dimensional (3D) measurement of lesion size, which is more informative than measuring lesion area alone and has become widely accepted as a quantitative method to indicate drug efficacy in ameliorating CNV lesions. 5, 13, 14 Although ex vivo lesion measurements of L-CNV are robust and powerful, in vivo imaging analysis of lesions would allow longitudinal studies. Optical coherence tomography (OCT) is a non-invasive, in vivo imaging technique that generates high resolution, cross sectional images of biological systems. 15 The technique has found extensive use in ophthalmology 15, 16 providing detailed images for both the anterior and posterior segments of the eye 17 and has become an essential tool for the clinical evaluation of ocular pathologies such as wet AMD, 18 retinal tumors, [19] [20] [21] and retinal detachment. 22 Paralleling its rise to clinical prominence, OCT has been used preclinically to monitor disease progression, and OCT images have been shown to be comparable to histological characteristics in disease models, [23] [24] [25] [26] including L-CNV. 12, 27 However, to our knowledge, 3D quantification of lesions in OCT images has previously used specialized software that is not readily available or compatible with different systems. Moreover, the correlation between calculated lesion volume from OCT images and ex vivo choroidal flatmount 3D quantification has not been shown previously. In this study, we show that 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 simple quantification of lesion volumes from OCT images provides reproducible and comparable evaluation to the ex vivo analytical methods used in the L-CNV mouse model.
Methods

Animals
All animal experiments followed the guidelines of the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee. Wild-type female C57BL/6J mice, 6-8 weeks of age, were purchased from Jackson Laboratory (Bar Harbor, ME). These mice were anesthetized by intraperitoneal injections of 17.5 mg/kg ketamine hydrochloride and 2.5 mg/kg xylazine.
Laser-Induced model of Choroidal Neovascularization
Laser photocoagulation was performed as previously described. 28, 29 Briefly, eyes were dilated using 1% tropicamide, then underwent laser treatment using 50 µm spot size, 50 ms duration, and 250 mV pulses of an ophthalmic argon green laser, wavelength 532 nm, coupled to a slit lamp. A coverslip was used to allow viewing of the posterior pole of the eye. Each eye received 3 laser burns centered around the optic nerve at 12, 3, and 9 o'clock positions. The laser-induced damage to Bruch's membrane was identified by the appearance of a bubble at the site of laser application. Lesions in which bubbles 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 were not observed were excluded from the study. Where indicated, intravitreal injections of anti-mouse VEGF 164 neutralizing antibody (R&D Systems, Minneapolis, MN) (5 ng/eye) or vehicle (phosphate buffered saline) were given immediately after laser in a 0.5 µL volume using a 33-gauge needle. The needle was kept in place for 1 minute to prevent the reflux of solution when the needle was removed. Eyes were numbed with tetracaine solution before the injection, and triple antibiotic ointment was used immediately after the injection to prevent infection. A masked researcher undertook imaging and analysis to avoid bias.
Optical Coherence Tomography
OCT was performed at the indicated times using the Micron III intraocular imaging For the InVivoVue system, experiments were done separately by a second laboratory, with imaging conducted by JQ. Pupils of mouse eyes were dilated with 1% atropine and 2.5% phenylephrine hydrochloride. Mice were then anesthetized. One drop of 2.5% hydroxypropyl methylcellulose was administrated to eyes before examination. Three lateral images (nasal to temporal) were collected, starting at the meridian crossing through the center of the optic nerve head (ONH), and the corresponding L-CNV injury spots were identified by contrasts. Composite fundus images (1.4x1.4 mm, 400x100x1x1) were taken centered on the ONH. Corresponding high resolution B-scan (1.4x1.4 mm, 400x400x1x1) images were then obtained from swept L-CNV spots.
Quantification of Lesions as Ellipsoids
Quantification was performed as in 
Choroidal flatmount preparation and ex vivo CNV lesion volume quantification
Fourteen days post-laser, L-CNV mice were euthanized by carbon dioxide asphyxiation followed by cervical dislocation. Eyes were enucleated and fixed in 4% paraformaldehyde (PFA) overnight. The anterior segment and the retina were removed, and the remaining RPE/choroid/sclera was permeabilized by incubation with 0.3% Triton X-100 followed by incubation with rhodamine labeled Ricinus communis agglutinin I (Vector Labs, Burlingame, CA), in the dark for 45 minutes, to stain blood vessels. The staining step was followed by two washes with Tris buffered saline with 0.1% Tween-20 (TBST). Flatmounts of the choroid were prepared and mounted with Vectashield mounting medium (Vector Labs, Burlingame, CA) and Z-stack images were taken on an LSM700 confocal microscope (Zeiss, Thornwood, NY, USA). ImageJ software was used to analyze Z-stack images; the summation of the whole stained area in each section, multiplied by the distance between sections (3 µm) was used as an index for the CNV lesion volume. 28 The volumes of the three lesions in each eye were averaged and considered as an n=1 for statistical analysis.
Statistical analysis
Statistical analysis was performed with GraphPad Prism 6 software. CNV volume was compared between treatments using the Mann-Whitney test. The Spearman correlation coefficient was used to assess the correlation between lesion volumes measured by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 OCT and choroidal flatmounts. P-values ≤ 0.05 were considered statistically significant.
Results
Ellipsoid quantification in vivo is comparable to ex vivo analysis in L-CNV
Although Z-stack analysis of wholemounts gives robust and reproducible data, we sought a simple means of evaluating L-CNV lesion volume in vivo. Mice underwent OCT 14 days post-laser. Comparing volumetric measurements of OCT and agglutininstained wholemount Z-stacks, significant correlation was observed by two independent graders; grader 1 with ρ = 0.79, P<0.01 and grader 2 ρ = 0.78, P<0.05 (Fig. 2) . The intraobserver correlation (based on repeated analysis of the same dataset) was ρ = 0.9, P<0.001, while the interobserver correlation was ρ = 0.73, P<0.05.
Ellipsoid quantification is sensitive to different treatment conditions
In the L-CNV model, anti-VEGF antibodies have previously been shown to reduce CNV lesion volume, based on Z-stack image quantification, compared to vehicle treated controls. 30 We first sought to reproduce this amelioration in the CNV lesion size using the L-CNV mouse model and to compare the difference between treatment groups using both confocal microscopy and OCT. Quantification of CNV lesion volume using the standard Z-stack image method showed the expected significant reduction, about 35%, 31 in lesion volume after anti-VEGF treatment compared to vehicle controls (Fig. 3) . 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 Interestingly, CNV lesion volume calculated using this method from OCT images obtained 7 days after laser and injection also demonstrated a significant reduction, likewise about 35%, after anti-VEGF treatment (Fig. 4) . Similar results were obtained from images after 14 days (Fig. 4) . Importantly, OCT volume measurements significantly correlated with those measured by Z-stack quantification, after 7 days (ρ = 0.82, P<0.01) (Fig. 5A) , and after 14 days (ρ = 0.82, P<0.01) (Fig. 5B) .
Ellipsoid quantification is OCT platform-independent
To validate that our ellipsoidal volume measurement technique could be applied to images from another automated OCT system, we evaluated L-CNV lesions using OCT images obtained with the InVivoVue system. Laser burns were applied to mouse eyes and after 10 days, lesions were evaluated by OCT in vivo. Lesion volumes were calculated by ellipsoid volume equation, and again compared to volumetric measurements of CNV lesion volumes from agglutinin stained choroidal flatmounts ex vivo after 14 days. Interestingly, a significant correlation was again observed between ellipsoid volume calculation and confocal Z-stack images (Fig. 6 ) (ρ = 0.75, P<0.05).
Similar correlation values were obtained by a second grader to account for interobserver variability (data not shown). Moreover, removing the peak point, which might be an outlier, did not change the correlation (ρ = 0.75, P<0.05).
Discussion
OCT imaging represents an essential adjunct in clinical diagnosis and monitoring of numerous ocular diseases, such as AMD. 20, 32 Evaluation of L-CNV in vivo using OCT imaging has been previously studied in different species such as monkeys, 33, 34 rabbits, 35 and rats. 27, 36, 37 Others have evaluated OCT in the mouse model of L-CNV used here by comparing OCT imaging to immunostaining and histological analyses. 12, 38, 39 However, in this study, we compared for the first time OCT quantification of L-CNV lesions to the robust and commonly used ex vivo agglutinin stained choroidal wholemount quantification method, which allows volumetric measurements of L-CNV lesions through Z-stack sections. 5, 13 We saw excellent correlation between the two methods using different OCT imaging systems.
Quantification of OCT images usually requires specialized, proprietary software that is not necessarily compatible with multiple imaging systems. In this study, we showed that quantitative OCT analysis by a simple method allowed in vivo evaluation and monitoring of choroidal lesions in the L-CNV model using two of the most commonly used OCT imaging systems. Although we used ImageJ for analysis, the radii measurements needed for ellipsoid volume could be done using any image-editing program.
Quantification of L-CNV lesions, obtained from either Micron or InVivoVue OCT images, using an ellipsoid volume calculation, provides reproducible and comparable results to the standard ex vivo quantification method. Consistently, we observed a significant correlation, by two independent graders, between OCT images obtained at day 7, 10, or 14 post-laser, and Z-stack confocal measurements at day 14. However, due to the difference in scaling of the Micron III and InVivoVue imaging systems; calculated lesion volumes by Micron OCT were uniformly larger than those calculated by confocal microscopy. Tissue shrinkage during fixation may also contribute to this finding. Alternatively, since the length of the lesion (dimension c) on the InVivoVue was obtained from en face images directly, not from vertical scans as was done with the Micron III system, this might induce some differences in the final calculation. Thus, using the same volumetric measurement system throughout the analysis of an experiment is important.
Our method also applies to OCT imaging to assess pharmacotherapeutic efficacy. Here, as proof of concept, we used the standard anti-VEGF antibody treatment, versus vehicle treatment, to ameliorate CNV lesion volume. To our knowledge, this is the first use of OCT to show therapeutic effect in the murine L-CNV model, although OCT has been used similarly in macaques. 34 As we show, OCT can be used to monitor drug response longitudinally in the same animal, reducing animal usage and enabling timecourse comparisons. For instance, we noted that mean L-CNV lesion volumes decreased from Day 7 to Day 14 (Fig. 4, 5 ), but the distinction between anti-VEGF and vehicle treatments remained about 35% as previously shown. 31 OCT analysis is also rapid. Preparation of choroidal flatmounts for the quantification of L-CNV lesion volume is a technically involved and time-consuming technique, requiring at least one overnight step and considerable confocal imaging time, as well as expensive reagents (fluorescent agglutinin in particular). 5 Conversely, acquiring multiple images on an OCT system takes about 5 -10 minutes per eye followed by 5 minutes for calculation of the lesion volume. Therefore, our ellipsoid volume quantification method represents an inexpensive, rapid, yet reliable quantification method for lesions from OCT images. Despite that, it is important to mention that OCT quantification is not a replacement for the Z-stack confocal measurement. However, it might provide an early prediction of therapeutic effects as well as a second evaluation method for CNV lesion volume.
One limitation of this method is the manual detection of CNV lesion dimensions, which might introduce bias to treatment conditions. However, this can be avoided when the experimenter is masked to treatments throughout imaging and analysis, as well as using at least two independent graders for volumetric analysis. True CNV lesion shape is likely not a simple ellipsoid; therefore, using a simple ellipsoid volume measurement may overestimate irregularly shaped lesions. 39 However, following from this, in experiments comparing CNV-lesion reducing therapies to control conditions it is likely that our method would be quite conservative (by potentially overestimating lesion volume and thus underestimating treatment effects), which might be considered as a strength. Like any OCT analysis, our method also requires a clear cornea and lens, and lesions in or near the central retina. This method is also limited to disease models that involve localized lesions that can be demarcated by OCT, such as L-CNV. However, a strength of our method is that it can be used to calculate volumes from the L-CNV murine model using different automated imaging systems, specifically the Micron and InVivoVue products.
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